Masahiro Takihata

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Paresh Dandona, Pieter Gillard, Peter Senior et al. · Diabetes Care · 2018 · 252 citations

Medicine, Pharmacology, Pharmacotherapy +15

Comparative study of sitagliptin with pioglitazone in Japanese type 2 diabetic patients: the <scp>COMPASS</scp> randomized controlled trial

Masahiro Takihata, Akinobu Nakamura, Kazuki Tajima et al. · Diabetes Obesity and Metabolism · 2012 · 41 citations

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

Takashi Iizuka, Kotaro Iemitsu, Masahiro Takihata et al. · Journal of Clinical Medicine Research · 2015 · 39 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Canagliflozin Increases Calorie Intake in Type 2 Diabetes Without Changing the Energy Ratio of the Three Macronutrients: CANA-K Study

Ikuro Matsuba, Akira Kanamori, Masahiro Takihata et al. · Diabetes Technology & Therapeutics · 2020 · 38 citations

Agriculture, Nutrition, Pharmacotherapy +17

Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study

Kotaro Iemitsu, Takashi Iizuka, Masahiro Takihata et al. · Journal of Clinical Medicine Research · 2016 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17